Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Interferon-β/natalizumab

Autoimmune hepatitis (first report with natalizumab): case report

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Interferon-β/natalizumab. React. Wkly. 1086, 14–15 (2006). https://doi.org/10.2165/00128415-200610860-00043

    Download citation

    Keywords

    • Hepatitis
    • Multiple Sclerosis
    • Lipase
    • Amylase
    • Natalizumab